Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/16816
Title: Effect of informed consent on patient characteristics in a stroke thrombolysis trial
Authors: Thomalla, Götz;Boutitie, Florent;Fiebach, Jochen B;Simonsen, Claus Z;Nighoghossian, Norbert;Pedraza, Salvador;Lemmens, Robin;Roy, Pascal;Muir, Keith W;Heesen, Christoph;Ebinger, Martin;Ford, Ian;Cheng, Bastian;Cho, Tae-Hee;Puig, Josep;Thijs, Vincent;Endres, Matthias;Fiehler, Jens;Gerloff, Christian
Issue Date: 27-Aug-2017
EDate: 2017-08-27
Citation: Neurology 2017; online first: 27 August
Abstract: Objective: To determine whether the manner of consent, i.e., informed consent by patients themselves or informed consent by proxy, affects clinical characteristics of samples of acute stroke patients enrolled in clinical trials. Methods: We analyzed the manner of obtaining informed consent in the first 1,005 patients from WAKE-UP, an investigator-initiated, randomized, placebo-controlled trial of MRI-based thrombolysis in stroke patients with unknown time of symptom onset running in 6 European countries. Patients providing informed consent by themselves were compared with patients enrolled by proxy consent. Baseline clinical measures were compared between groups. Results: In 359 (35.7%) patients, informed consent was by proxy. Patients with proxy consent were older (median 71 vs 66 years, p < 0.0001) and had a higher frequency of arterial hypertension (58.2% vs 43.4%, p < 0.0001). They showed higher scores on the NIH Stroke Scale (median 11 vs 5, p < 0.0001) and more frequently aphasia (73.7% vs 20.0%, p < 0.0001). The rate of proxy consent varied among countries (p < 0.0001), ranging from 77.1% in Spain to 1.2% in Denmark. Conclusions: Patients recruited by proxy consent were older, had more severe strokes, and had higher prevalence of aphasia than those with capacity to give personal consent. Variations in the manner of consent across countries may influence trial results. Clinicaltrials.gov and Clinicaltrialsregister.eu identifiers: NCT01525290 (clinicaltrials.gov); 2011-005906-32 (clinicaltrialsregister.eu).
URI: http://ahro.austin.org.au/austinjspui/handle/1/16816
DOI: 10.1212/WNL.0000000000004414
ORCID: 0000-0002-6614-8417
PubMed URL: https://www.ncbi.nlm.nih.gov/pubmed/28842449
Type: Journal Article
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.